Wednesday, May 23, 2018 9:50:44 PM
For the record it is me too. I do not need Kim telling me things from this side of the pond, to believe they are occurring. I would hope information is controlled....coming out of Vietnam. I suppose anyone could make things appear like they are coming out of Vietnam. Maybe we will learn differently.
In the meantime another thing from 247 marketnews....
https://www.marketwatch.com/story/kraig-labs-new-dna-synthesis-breakthrough-could-unlock-the-revenue-streams-door-2018-05-23?siteid=bigcharts&dist=bigcharts
May 23, 2018 (247MarketNews via COMTEX) -- The problem with too many biotech business models is that their revenue streams are one dimensional, in that they are often generated by one drug, but the upside is that the need to diversify revenues makes smaller biotechs very sexy acquisition targets.
The current biotech acquisition party started when Gilead Sciences GILD, +0.50% announced that it was going to acquire Kite Pharma for $11.9 billion, which was followed by Celgene's CELG, +1.37% $9 billion takeover of Juno Therapeutics, and Sanofi's SNY, -0.82% $11.6 billion Bioverativ and $4.8 billion Ablynx double play.
Development of multiple revenue streams is so important to biotechs that Goldman Sachs GS, -0.08% asked, in their "The Genome Revolution" report, "Is curing patients a sustainable business model?"
Kraig Biocraft Laboratories (otcqb:KBLB), which developed what many consider to be the best spider silk fiber technology, is in the enviable position of being a small biotech company that may fill the needs of the many product developers and engineers, which, in turn, could potentially unlock multiple future revenue streams.
For a company that currently only has one revenue stream, a contract to produce customized fibers for the US Army, that may sound like a stretch, but recent developments, which include being green lighted to set up production in Vietnam, after receiving an invitation from the Vietnamese government, indicate that the Company is gearing up to carve out its portion of the $5 billion raw silk fibers market, as well as a broad cross section of applications in the $160 billion (estimated) technical fibers market and the budding smart textile markets.
Kraig Labs' transgenic silkworks are designed produce high performance recombinant spider silk fibers that are ecologically friendly and biocompatible.
Spider silk is said to be 10 times greater than steel, while some silks are nearly as elastic as rubber, and, according to some studies, can be two to three times tougher than even Kevlar. These eye popping properties have motivated a slew of researchers to target this fiber to be the basis for protective clothing and body armor applications, as well as other potential military applications including technical undergarments and more practical ropes.
It's believed that spider silk may also be the foundation to many lightweight products, including air bags, seat belts, flexible bridge suspension cables, sports helmets and motor vehicle panels, as well as the next generation of medical breakthroughs, as studies have shown spider silk to be antimicrobial, biocompatible, hypoallergenic and totally biodegradable. Spider silk is a biomaterial that could be the platform on which to develop many medical technologies, like better bandages, elastic ligaments, and artificial tendons and even biodegradable water bottles.
The list of potential uses is way too long to list here, but, if you have a few spare hours, prepare to be blown away by what the eggheads are dreaming up.
The stakes are high, so today's announcement that Kraig Labs developed new breakthrough spider silk DNA synthesis protocols, which the Company believes will accelerate the new super fibers development process, as well as reduce the R&D process costs. The goal is to produce fibers with even greater strength and flexibility than the Company's current recombinant spider silk offerings, for "wider applications in military and high performance technical textile markets."
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM